Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
D-LIMONENE
ID: ALA449062
Max Phase: Phase
Molecular Formula: C10H16
Molecular Weight: 136.24
Molecule Type: Small molecule
Associated Items:
ID: ALA449062
Max Phase: Phase
Molecular Formula: C10H16
Molecular Weight: 136.24
Molecule Type: Small molecule
Associated Items:
Synonyms (18): (d)-limonene | Cajeputene | Cinene | D-limonene | Dipenten | Dipentene | Dipentene no. 122 | Eulimen | Kautschin | Limonene | Limonene, d- | Limonene, dl- | Nesol | Orange x | FEMA NO. 2633 | NSC-21446 | NSC-757069 | NSC-844
Synonyms from Alternative Forms(18):
Canonical SMILES: C=C(C)[C@H]1CC=C(C)CC1
Standard InChI: InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,10H,1,5-7H2,2-3H3/t10-/m0/s1
Standard InChI Key: XMGQYMWWDOXHJM-JTQLQIEISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: Yes | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 136.24 | Molecular Weight (Monoisotopic): 136.1252 | AlogP: 3.31 | #Rotatable Bonds: 1 |
Polar Surface Area: 0.00 | Molecular Species: | HBA: 0 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 0 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.22 | CX LogD: 3.22 |
Aromatic Rings: 0 | Heavy Atoms: 10 | QED Weighted: 0.49 | Np Likeness Score: 2.36 |
1. Jorgensen WL, Duffy EM.. (2000) Prediction of drug solubility from Monte Carlo simulations., 10 (11): [PMID:10866370] [10.1016/s0960-894x(00)00172-4] |
2. Olagnier D, Costes P, Berry A, Linas MD, Urrutigoity M, Dechy-Cabaret O, Benoit-Vical F.. (2007) Modifications of the chemical structure of terpenes in antiplasmodial and antifungal drug research., 17 (22): [PMID:17904365] [10.1016/j.bmcl.2007.09.056] |
3. Kubo I, Muroi H, Kubo A.. (1994) Naturally occurring antiacne agents., 57 (1): [PMID:8158169] [10.1021/np50103a002] |
4. Perrucci S, Macchioni G, Cioni PL, Flamini G, Morelli I.. (1995) Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi., 58 (8): [PMID:7595592] [10.1021/np50122a018] |
5. Huss U, Ringbom T, Perera P, Bohlin L, Vasänge M.. (2002) Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay., 65 (11): [PMID:12444669] [10.1021/np020023m] |
6. Himejima M, Kubo I.. (1992) Antimicrobial agents from Licaria puchuri-major and their synergistic effect with polygodial., 55 (5): [PMID:1517735] [10.1021/np50083a010] |
7. Massarelli I, Imbriani M, Coi A, Saraceno M, Carli N, Bianucci AM.. (2009) Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals., 44 (9): [PMID:19272677] [10.1016/j.ejmech.2009.02.014] |
8. Graebin CS, Madeira Mde F, Yokoyama-Yasunaka JK, Miguel DC, Uliana SR, Benitez D, Cerecetto H, González M, Rosa RG, Eifler-Lima VL.. (2010) Synthesis and in vitro activity of limonene derivatives against Leishmania and Trypanosoma., 45 (4): [PMID:20116908] [10.1016/j.ejmech.2009.12.061] |
9. Greene N, Fisk L, Naven RT, Note RR, Patel ML, Pelletier DJ.. (2010) Developing structure-activity relationships for the prediction of hepatotoxicity., 23 (7): [PMID:20553011] [10.1021/tx1000865] |
10. Ekins S, Williams AJ, Xu JJ.. (2010) A predictive ligand-based Bayesian model for human drug-induced liver injury., 38 (12): [PMID:20843939] [10.1124/dmd.110.035113] |
11. Duelund L, Amiot A, Fillon A, Mouritsen OG.. (2012) Influence of the active compounds of Perilla frutescens leaves on lipid membranes., 75 (2): [PMID:22272932] [10.1021/np200713q] |
12. Furneri PM, Mondello L, Mandalari G, Paolino D, Dugo P, Garozzo A, Bisignano G.. (2012) In vitro antimycoplasmal activity of Citrus bergamia essential oil and its major components., 52 [PMID:22465092] [10.1016/j.ejmech.2012.03.005] |
13. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
14. Zhang JS, Zhao NN, Liu QZ, Liu ZL, Du SS, Zhou L, Deng ZW.. (2011) Repellent constituents of essential oil of Cymbopogon distans aerial parts against two stored-product insects., 59 (18): [PMID:21819085] [10.1021/jf202266n] |
15. Ntalli NG, Ferrari F, Giannakou I, Menkissoglu-Spiroudi U.. (2010) Phytochemistry and nematicidal activity of the essential oils from 8 Greek Lamiaceae aromatic plants and 13 terpene components., 58 (13): [PMID:20527965] [10.1021/jf100797m] |
16. Kordali S, Kesdek M, Çakir A.. (2007) Toxicity of monoterpenes against larvae and adults of Colorado potato beetle, Leptinotarsa decemlineata Say (Coleoptera: Chrysomelidae), 26 (3): [10.1016/j.indcrop.2007.03.009] |
17. Han J, Kim SI, Choi BR, Lee SG, Ahn YJ.. (2011) Fumigant toxicity of lemon eucalyptus oil constituents to acaricide-susceptible and acaricide-resistant Tetranychus urticae., 67 (12): [PMID:21674753] [10.1002/ps.2216] |
18. Tong F, Coats JR.. (2012) Quantitative structure-activity relationships of monoterpenoid binding activities to the housefly GABA receptor., 68 (8): [PMID:22461383] [10.1002/ps.3280] |
19. PubChem BioAssay data set, |
20. Vandresen F, Falzirolli H, Almeida Batista SA, da Silva-Giardini AP, de Oliveira DN, Catharino RR, Ruiz AL, de Carvalho JE, Foglio MA, da Silva CC.. (2014) Novel R-(+)-limonene-based thiosemicarbazones and their antitumor activity against human tumor cell lines., 79 [PMID:24727464] [10.1016/j.ejmech.2014.03.086] |
21. Bibi H, Reany O, Waisman D, Keinan E.. (2015) Prophylactic treatment of asthma by an ozone scavenger in a mouse model., 25 (2): [PMID:25499435] [10.1016/j.bmcl.2014.11.035] |
22. DrugMatrix, [10.6019/CHEMBL3885881] |
23. Durço AO, de Souza DS, Heimfarth L, Miguel-Dos-Santos R, Rabelo TK, Oliveira Barreto T, Rhana P, Santos Santana MN, Braga WF, Santos Cruz JD, Lauton-Santos S, Santana-Filho VJ, Barreto RSS, Guimarães AG, Alvarez-Leite JI, Quintans Júnior LJ, Vasconcelos CML, Santos MRVD, Barreto AS.. (2019) d-Limonene Ameliorates Myocardial Infarction Injury by Reducing Reactive Oxygen Species and Cell Apoptosis in a Murine Model., 82 (11): [PMID:31710486] [10.1021/acs.jnatprod.9b00523] |
24. Unpublished dataset, |
Source(5):